Andrew Orry
2Patents
0h-index
7Co-inventors
21Inventor score
Filing activity: Mar 11, 2022 → Mar 18, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11697650B2 | Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors | Human Necessities | 0 | Active |
| US11834450B2 | Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.